Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.

Slides:



Advertisements
Similar presentations
Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Advertisements

Down Alert Function of the GlucoWatch® G2 TM Biographer (GW2B) During Insulin- induced Hypoglycemia in Children Eva Tsalikian 1, Craig Kollman 2, Rosanna.
Nallasamy K, Jayashree M, Singhi S, Bansal A
Diabetes Self-Management Profile- Revised for Conventional and Flexible Insulin Regimens Wysocki, T. 1, Xing, D. 2, Fiallo-Scharer, R. 3, Doyle, E. 4,
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
Hypoglycemia DR. Hamed Habib Consultant pediatrician.
Diabetes Control in Youth: The American Experience Georgeanna J. Klingensmith, MD Keystone Colorado July 2008.
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
1 Progress Towards an Artificial Pancreas for T1D WILLIAM TAMBORLANE, MD Chief of Pediatric Endocrinology, Yale University, Deputy Director, Yale Center.
Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Accuracy of the FreeStyle Navigator ™ Continuous Glucose Monitor Diabetes Research in Children Network Larry Fox, 1 Roy Beck, 2 Stuart Weinzimer, 3 Katrina.
Introduction Hypothesis Conclusions and Limitations Specific Aims Effects of Apple Cider Vinegar on Postprandial Glucose Levels in Adults with Type 2 Diabetes.
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the GlucoWatch® G2 TM Biographer in the Management of Type 1 Diabetes.
Accuracy of the A1cNow ® in Children with T1D. Diabetes Research in Children Network Larry Fox, 1 Dongyuan Xing, 2 Katrina Ruedy, 2 Roy Beck, 2 Craig Kollman,
Limitations of Statistical Measures of Error in Assessing the Accuracy of Glucose Sensors Craig Kollman1, Darrell Wilson2, Tim Wysocki3, Rosanna Fiallo-Scharer4,
By: Heather Boyd Diabetes is a serious chronic disease that can be managed through lifestyle changes and medication. Almost 24 million Americans have.
Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive Featured Article: Carmel.
INSULIN THERAPY IN TYPE 1 DIABETES
Diabetes Research in Children Network (DirecNet) Outpatient Pilot Study to Evaluate the Feasibility of Computer-Based Data Acquisition and Transmission.
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
A 5-center CRC-based Study of the Accuracy of the GlucoWatch® G2 TM Biographer in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1, Bruce.
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
Diabetes Technology Update
Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.
Mealtime Glycemic Excursions in Pediatric Subjects with Type 1 Diabetes: Results of the Diabetes Research in Children (DirecNet) Accuracy Study Study Group.
Closed-Loop Insulin Delivery in Children
L.M. Fisk, A.J. Le Compte, G.M. Shaw, S. Penning, T. Desaive, J.G. Chase Pilot Trial of STAR in Medical ICU INTRODUCTION Background: Accurate glycemic.
Abstract Background: As part of a study to evaluate the accuracy of the GlucoWatch ® G2 TM Biographer and the Continuous Glucose Monitoring System (CGMS.
Diabetes Control and Complications Trial (DCCT) Results indicate that most youth with T1DM should be treated intensively in order to reduce the risk of.
Background: DirecNet Diabetes Research in Children Network NIH funded collaborative study group 5 clinical centers, central laboratory, coordinating center,
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Diabetes Research in Children Network Pilot Study of the Navigator TM Continuous Glucose Monitoring System in Children with Type 1 Diabetes: Safety, Tolerability,
Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.
Event-Based Assessments of Sensor Accuracy during Exercise-Induced Reductions in Glucose in Children with Type 1 Diabetes Craig Kollman, 1 Darrell Wilson,
Impact of Exercise on Overnight Glycemic Control in Children with Type 1 Diabetes (T1DM) Eva Tsalikian 1 ; Roy Beck 2 ; Peter Chase 3 ; Tim Wysocki 4 ;
Monthly Journal article review: Vimmi Kang PGY 2
Use of The FreeStyle Navigator TM Continuous Glucose Monitoring System in Children on Glargine- based Multiple Daily Injection Therapy Stuart Weinzimer.
Use of the FreeStyle Navigator ™ Continuous Glucose Monitoring System in Children with Type 1 Diabetes Diabetes Research in Children Network L. A. Fox,
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Lack of Effectiveness of the GlucoWatch Biographer (GW2B) in Altering Glycemic Control in Children with Type 1 Diabetes H. Peter Chase 1, Roy Beck 2, William.
A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS™) Sensor During Hypoglycemia in the Diabetes Research in Children.
Utility of CGMS as a Measure of Glycemic Control in Children with Type 1 Diabetes (T1DM) Rosanna Fiallo-Scharer, MD for.
Reliability of two indices of the biologic variability in glycosylation among children and adolescents with T1DM Darrell M Wilson 1, Rosanna Fiallo-Scharer.
PowerHour Information 03/09/2011.  Background  Description  Vision  Mission  Measurements  Participation Requirements.
Effectiveness of Early Intensive Therapy On β-Cell Preservation in Type 1 Diabetes Featured Article: Bruce Buckingham, M.D., Roy W. Beck, M.D., P.H.D.,
Evaluation of Factors Affecting CGMS Calibration Bruce Buckingham, 1 Craig Kollman, 2 Roy W Beck, 2 Andrea Kalajian, 2 Rosanna Fiallo-Scharer, 3 Michael.
Accuracy Study of the Medtronic Minimed Continuous Glucose Monitoring System (CGMS) and GlucoWatch® G2TM Biographer (GW2B) in Children with Type 1 Diabetes.
Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free- Living, Randomized Clinical Trial Featured Article: Roman Hovorka,
Alterations in White Matter Structure in Young Children With Type 1 Diabetes Featured Article: Naama Barnea-Goraly, Mira Raman, Paul Mazaika, Matthew Marzelli,
Performance of the DCA 2000 ® + Analyzer for Measurement of Hemoglobin A1 c Levels in Children with T1DM in a DirecNet Outpatient Clinical Trial.
The Diabetic Retinopathy Clinical Research Network Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control (Protocol M) 11.
Michelle D. Stancil, RN, BSN, CDE Blix M. Rice, MBA, CHFP October 16, 2015 Putting a Diabetes Educator in Your Pocket: A Novel Approach to Disease Management.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
Source:
/ 161 Saudi Diploma in Family Medicine Center of Post Graduate Studies in Family Medicine EBM Therapy Articles Dr. Zekeriya Aktürk
DirecNet Study of the Accuracy of the Navigator Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes Darrell Wilson 1,
The Physiological Variations of Plasma Glucose Concentrations in Healthy, Non-Diabetic Children: Use of Continuous Glucose Sensors Nelly Mauras, Roy Beck,
Lecturer: Bahiya Osrah.  It is a chronic disease associated with hyperglycemia (increased blood glucose level) & glucourea (presence of glucose in urine)
Background notes Audience: diabetes professional (entry level), patients with diabetes First slide: ADD your name/institution ‘Sponge bob’ slide: hemoglobin.
1 INTRODUCTION Nearly 25% of diabetes patients use insulin Many practitioners: –Are uncomfortable with insulin dosing –Base dosing decisions on empiric.
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Baseline characteristics
Nallasamy K, Jayashree M, Singhi S, Bansal A
Safety and efficacy of insulin guideline for controlling perioperative hyperglycemia Marwa Amer PharmD Candidate1, Mark Shelly MD2, Dianne Lee PharmD Candidate1,
D2d participating clinical sites
Faster-Acting Insulins
Younger Patients With Type 1 Diabetes: Can We Optimize Their Insulin Therapy?
PowerPoint 16:9 Screen Ratio Template *
in Youth With Type 1 Diabetes
Presentation transcript:

Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring. Darrell M. Wilson 1, Kimberly Caswell 1, H. Peter Chase 2, Michael Tansey 3, Larry A. Fox 4, Stuart Weinzimer 5, Dongyuan Xing 6, Roy Beck 6, Craig Kollman 6, William Tamborlane 5, Katrina Ruedy 6 and the Diabetes Research in Children Network (DirecNet) Study Group. 1 Stanford, CA; 2 Denver, CO; 3 Iowa City, IA; 4 Jacksonville, FL; 5 New Haven, CT; 6 Tampa, FL

Introduction: Bedtime snacks are frequently employed in the treatment of children with type 1 diabetes to prevent nocturnal hypoglycemia, and the inclusion of protein and/or fat is commonly recommended. Methods: Ten subjects with T1DM (age 6-18y, HbA1c 6.9 ± 0.5%) enrolled in a pilot trial evaluating the Navigator glucose sensor completed a study comparing the effect of bedtime snack fat content on nocturnal hypoglycemia. On ≥12 separate nights, each subject received either a low-fat (30 gm carbohydrate, 3 gm protein, 1 gm fat; 138 kCal) or high-fat (30 gm CHO, 2 gm protein, 20 gm fat; 320 kCal) snack in random order. Subjects checked their glucose and via a website, were assigned to a high or low fat snack. Subjects used their usual evening snack algorithm to determine the size (in 15 gram carbohydrate increments). Data were from nights with at least 5h (average of 8.1±1.3h) of sensor data after the snack. Results: Average BG (mg/dl) on 128 valid study nights before snack were similar in both groups (163 ± 55, high fat; 164±53, low fat). The proportion of nights with hypoglycemia (sensor glucose ≤70) was similar in both groups (23% high fat vs 21% low fat). Likewise, the proportion of nights with hyperglycemia (sensor glucose ≥200) was similar in both groups (68% high fat vs 61% low fat). Conclusion: Even very well controlled children and adolescents with T1DM have a very high frequency of high and low glucose levels. However, the altering the amount of fat in the bedtime snack had no impact on frequency of hyperglycemia or hypoglycemia. This study also highlights the feasibility of web based research in patients’ home environment. Abstract

Background Hypoglycemia is a frequent and potentially serious complication of intensive insulin therapy, particularly in children with type 1 diabetes Almost half of severe hypoglycemia episodes occur overnight, while children are not being actively supervised or monitored Common practice suggests the ingestion of a fat-containing bedtime snack may reduce the risk of nocturnal hypoglycemia, presumably via delaying carbohydrate absorption

Rationale The purpose of this outpatient study was to determine whether, among children with type 1 diabetes (T1DM) utilizing insulin pump, a pre-bedtime snack with a relatively high fat content provides greater protection from nocturnal hypoglycemia than a snack containing the same amount of carbohydrate and protein, but a lower fat content.

Methods - Subjects Ten subjects 6-<18 years old with T1DM for over a year and using an insulin infusion pump Mean hemoglobin A 1C - 6.9% Enrolled in a pilot trial evaluating the Abbott Navigator ® Continuous Glucose Monitoring System On ≥12 nights, subjects were randomized to a carbohydrate snack or a carbohydrate plus fat snack

Sensor Delivery Unit ReceiverTransmitter Sensor Abbott FreeStyle Navigator Sensor

Snacks LOW FAT 30 gm CHO 2.5 gm protein 1.3 gm fat 138 kCal HIGH FAT 30 gm CHO 2 gm protein 20 gm fat 320 kCal

Web-based Snack Assignment and Data Collection Subjects logged on the study website and –entered the pre-snack glucose level –entered the level of activity during that day –used usual practices for determining the amount of carbohydrate (in 15-gram increments) –entered the amount of insulin to be taken to cover the snack A minimization algorithm was used to determine the order of the snack types based on –the pre-snack meter glucose level –the self-reported amount of activity during that day

Web-based Snack Assignment and Data Collection

Outcome Measures The primary outcome was hypoglycemia –at least one glucose value ≤70 mg/dL on either the Navigator or the FreeStyle meter Hyperglycemia was defined as at least one glucose value ≥200 mg/dL and at least 50 mg/dL above pre-snack glucose on either the Navigator or the FreeStyle meter. At least 12 nights with at least 5 hours of sensor data were collected

Results High fatLow fat Nights (#)6266 Pre-snack Meter Glucose (M±SD)163 ± ± 53 Pre-snack Sensor Glucose (M±SD)162 ± ± 54 Mean Sensor Glucose Overnight * (M±SD) 171 ± ± 45 Hypoglycemia #(%)12 (19%)13 (20%) Hyperglycemia #(%)22 (35%)20 (30%) *p-value=0.02

Time to Hyperglycemia for the high-fat and low-fat Nights. Hyperglycemia was defined as the first glucose value ≥200 mg/dL and at least 50 mg/dL above pre-snack Navigator glucose. *p-value from permutation test to account for correlated data from the same subject

Time to Hypoglycemia for the high-fat and low-fat Nights. Hypoglycemia was defined as the first glucose value ≤70 mg/dL. *p-value from permutation test to account for correlated data from the same subject

The Mean Sensor glucose value at each hour in each group after bedtime snack. BG at baseline (hour zero) is the average sensor reading over the 30 minutes prior to the snack. BG at each hour after snack is the average of sensor readings within ± 15 minutes of the hour *p-value<0.01 at 5 hours after snack High Fat Low Fat *

Results There were no meaningful differences between the high and low fat snacks on the frequency of hyperglycemia or hypoglycemia. –Mean overnight glucoses were higher in the high fat snack There was no meaningful difference in the timing of hyper- or hypoglycemia This study highlights the feasibility of web- based research in patients’ home environment.

Discussion The addition of fat to a bedtime snack does not improve overnight glycemic control and may cause hyperglycemia This study demonstrates the utility of web-based randomization and data collection systems in examining clinically important outpatient problems in patients with chronic diseases.